3//SEC Filing
OrbiMed Capital GP VI LLC 3
Accession 0000899243-18-019972
CIK 0001658247other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 8:46 PM ET
Size
7.5 KB
Accession
0000899243-18-019972
Insider Transaction Report
Form 3
OrbiMed Capital GP VI LLC
10% Owner
Holdings
- (indirect: See Footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (1,739,282 underlying)
ORBIMED ADVISORS LLC
10% Owner
Holdings
- (indirect: See Footnotes)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (1,739,282 underlying)
Footnotes (3)
- [F1]The 5,722,239 shares of Series B Preferred Stock held by the reporting person is convertible, at any time, at the holder's election, at a ratio of 3.29 to one share of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stock will automatically convert at a ratio of 3.29 to one share of the Issuer's common stock. The Series B Preferred Stock has no expiration date.
- [F2]These securities are held of record by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OPI VI, and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein.
- [F3]This report on Form 3 is jointly filed by GP VI and Advisors. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001682115
Filing Metadata
- Form type
- 3
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 8:46 PM ET
- Size
- 7.5 KB